Finding the best sequence for Next-Gen breast cancer drugs
Disease control
Not yet recruiting
This study aims to find the best order to use two newer, targeted breast cancer drugs (called ADCs) after standard first-line treatment stops working. It will enroll 40 adults with advanced HR+/HER2- breast cancer whose cancer has progressed on prior therapy. Researchers will com…
Phase: PHASE4 • Sponsor: Yan Xue • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC